This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2016 Dec 1;122(23):3592-3595.

doi: 10.1002/cncr.30352. Epub 2016 Sep 20.

Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo

Nicole G Chau¹, Robert I Haddad¹

Affiliations

PMID: 27649273
DOI: 10.1002/cncr.30352

Free article

Editorial

Antiangiogenic agents in head and neck squamous cell carcinoma: Tired of going solo

Nicole G Chau et al. Cancer. 2016.

Free article

. 2016 Dec 1;122(23):3592-3595.

doi: 10.1002/cncr.30352. Epub 2016 Sep 20.

Authors

Nicole G Chau¹, Robert I Haddad¹

Affiliation

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts.

PMID: 27649273
DOI: 10.1002/cncr.30352

No abstract available

PubMed Disclaimer

Comment on

A phase 2 study of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Jimeno A, Posner MR, Wirth LJ, Saba NF, Cohen RB, Popa EC, Argiris A, Grossmann KF, Sukari A, Wilson D, Zhang X, Sun J, Glasser C, Attie KM, Sherman ML, Pandya SS, Weiss J. Jimeno A, et al. Cancer. 2016 Dec 1;122(23):3641-3649. doi: 10.1002/cncr.30317. Epub 2016 Sep 20. Cancer. 2016. PMID: 27648727 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Wiley
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information